Alzamend Neuro, Inc. (ALZN) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2026 | -$8.77M | -95.0% |
| 2025 | -$4.50M | +54.7% |
| 2024 | -$9.94M | +33.2% |
| 2023 | -$14.87M | -20.7% |
| 2022 | -$12.32M | -148.8% |
| 2021 | -$4.95M | -11.9% |
| 2020 | -$4.42M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2026 | -$8.77M | -95.0% |
| 2025 | -$4.50M | +54.7% |
| 2024 | -$9.94M | +33.2% |
| 2023 | -$14.87M | -20.7% |
| 2022 | -$12.32M | -148.8% |
| 2021 | -$4.95M | -11.9% |
| 2020 | -$4.42M | — |